Skip to main content

Anti-Cancer Drug Design is now published as Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.

Publisher: Cognizant Communication Corporation

Volume 13, Number 5, 1998
Purchase this issue

Favourites:
ADD

Synthesis, antiviral and antiproliferative activity of some N-benzenesulphonyl-2-(2- or 3-pyridylethyl)-benzimidazoles
pp. 397-406(10)
Authors: Garuti, L; Roberti, M; Rossi, T; Cermelli, C; Portolani, M; Malagoli, M; Castelli, M

Favourites:
ADD

Synthesis, DNA binding, topoisomerase II inhibition and cytotoxicity of two guanidine-containing anthracene-9,10-diones
pp. 407-415(9)
Authors: Routier, S; Bernier, J-L; Catteau, J-P; Riou, J-F; Bailly, C

Favourites:
ADD

Molecular modelling and footprinting studies of DNA minor groove binders: bisquaternary ammonium heterocyclic compounds
pp. 463-488(26)
Authors: Slickers, P; Hillebrand, M; Kittler, L; Löber, G; Sühnel, J

Favourites:
ADD

Antitumor activity of paclitaxel (taxol) analogues on MDR-positive human cancer cells
pp. 489-499(11)
Authors: Distefano, M; Scambia, G; Ferlini, C; Gallo, D; De Vincenzo, R; Filippini, P; Riva, A; Bombardelli, E; Mancuso, S

Favourites:
ADD
Favourites:
ADD

The complete issue is available for purchase

$60.00

Purchasing this issue will give you access to all of the articles listed above for 2 days. You may also purchase articles individually by visiting the abstract page of the article. The exact price (including tax) will be displayed in your shopping cart before you check out. You will be able to remove this item from your shopping cart at any time before you have completed check-out.

Add to cart

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more